Literature DB >> 3105404

The genetic aspects of neurofibromatosis.

J C Carey, B J Baty, J P Johnson, T Morrison, M Skolnick, J Kivlin.   

Abstract

Although the genetic pattern in NF has been definitely established as autosomal dominant, more precise data regarding penetrance, natural history, prevalence, and heterogeneity are needed for the counseling of families. NF is the prototypic disorder for the study of the biologic mechanisms of variable expressivity. The widely cited prevalence figure of Crowe is probably too high; thus the mutation ratio estimation in NF is among the highest in man but close to other common Mendelian disorders. With the existing data on frequency of Lisch nodules and with future prospective date on café-au-lait spot development, an age-of-onset penetrance curve for NF could be constructed for genetic counseling purposes. The segmental form of NF is of interest as cases of this presentation may be helpful in studying the hypothesis of human somatic mutation when DNA analysis is available. Guidelines for routine evaluation and ongoing health supervision of individuals with neurofibromatosis need to be developed; multidisciplinary NF clinics and collaborative study groups are appropriate settings for this undertaking. Neurofibromatosis is an important disorder for the study of the psychodynamic processes that families experience in dealing with uncertainty.

Entities:  

Mesh:

Year:  1986        PMID: 3105404     DOI: 10.1111/j.1749-6632.1986.tb48061.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

1.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

2.  NF1 single and multi-exons copy number variations in neurofibromatosis type 1.

Authors:  Apolline Imbard; Eric Pasmant; Audrey Sabbagh; Armelle Luscan; Magali Soares; Philippe Goussard; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanne-Chantelot; Dominique Vidaud; Pierre Wolkenstein; Béatrice Parfait
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

3.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Authors:  S M Huson; D A Compston; P Clark; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

Review 4.  Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.

Authors:  Verena Staedtke; Ren-Yuan Bai; Jaishri O'Neill Blakeley
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

5.  A genomic search for linkage of neurofibromatosis to RFLPs.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; J Kivlin; H Willard
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

Review 6.  Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Authors:  Aaron W James; Le Chang; Scott Genshaft; Sarah M Dry
Journal:  J Orthop       Date:  2014-11-26

Review 7.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

8.  Detection and characterization of NF1 microdeletions by custom high resolution array CGH.

Authors:  Eric Pasmant; Audrey Sabbagh; Julien Masliah-Planchon; Véronique Haddad; Marie-José Hamel; Ingrid Laurendeau; Jean Soulier; Béatrice Parfait; Pierre Wolkenstein; Ivan Bièche; Michel Vidaud; Dominique Vidaud
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

9.  Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.

Authors:  D A Stevenson; D H Viskochil; A F Rope; J C Carey
Journal:  Clin Genet       Date:  2006-03       Impact factor: 4.438

10.  Neurofibromatosis type 1 in Israel: survey of young adults.

Authors:  B Z Garty; A Laor; Y L Danon
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.